Mirati Therapeutics, Inc. (MRTX) has seen some recent action in the market and its shares closed at $219.97 yesterday. Traders are starting to take interest of MRTX as the shares traded as high as $222.20 and as low as $201.47 in the previous trading day.
Mirati Therapeutics, Inc. (MRTX) average trading volume is 498.66K. However, in the previous trading day Mirati Therapeutics, Inc. (MRTX) traded 1,441,351 shares. The 1st support level on MRTX is $215.95. MRTX 50day moving average is $175.21 and MRTX two hundred day moving average is $129.58.
Mirati Therapeutics, Inc. (MRTX) current performance has been indicated by the recent movement in MRTX shares. MRTX has performed 32.47% over the past 4 weeks, MRTX has performed 81.33% over the past 3 months and MRTX has shown 131.82% over the past 365 days. Mirati Therapeutics, Inc. (MRTX) has a 52 week range of $66.01 to $222.26. Mirati Therapeutics, Inc. (MRTX) is trading 233.24% from its 52 week low and 4.00% from its 52 week high. Mirati Therapeutics, Inc. (MRTX) is indicating a 11.02% short float indicating the quantity short in the float.
MRTX has 43.83M shares outstanding and 40.85M shares in the float. Mirati Therapeutics, Inc. (MRTX) presently has a market cap of $9.80B and income of -296.20M. The EPS next quarter for MRTX is -1.97 and projected EPS next year is -7.40%. The market cap of Mirati Therapeutics, Inc. (MRTX) at $9.80B represents how many Traders own shares of MRTX and is calculated off the last price ($219.97) of MRTX and the quantity of shares outstanding (43.83M) with Mirati Therapeutics, Inc. (MRTX).
Mirati Therapeutics, Inc. (MRTX) has total cash (mrq) of 647.18M, total cash per share (mrq) of 14.53, total debt of MRTX stands at 700k and total debt/equity (mrq) is 0.12. . Mirati Therapeutics, Inc. (MRTX) operational cash flow (ttm) is -193.12M, MRTX leveraged free cash flow (ttm) is -90.56M.
MRTX is trading 18.26% above (bullish) its SMA20, 33.14% above (bullish) its SMA50 and 89.59% above (bullish) its SMA200.